glp-1 anesthesia guidelines 2025 GLP-1 Medication Disclosure Before Anesthesia: Essential Pre-Surgery Guide glp 1 anesthesia guidelines 2025

Exploring DNA methylation, telomere length, mitochondrial DNA, and immune function in patients with Long-COVID

Effectiveness of herbal medicines for weight loss: a systematic review and meta-analysis of randomized controlled trials

Compared to the placebo group, those who received the silymarin saw a "significant decrease" in their levels of key diabetic markers hemoglobin A1C, fasting blood sugar, total cholesterol, low-density lipoprotein ("bad") cholesterol, and triglycerides.17 The second is a recent review published in the Annals of Hepatology in 2021, much of which relates to silymarin's effect on insulin resistance,18 a prominent marker for type 2 diabetes.19 Two of the studies referenced in the review were animal studies that administered 26.25-100mg/kg of silybin to rat subjects (equivalent to around 366-1,395mg for an 86kg, or 190lb, human) across 6-12 weeks

Understanding dose equivalence (and why it does not exist) This is the question everyone asks

Additionally, decreased expression of Sequestosome 1 (SQSTM1) in diabetic keratinocytes impairs autophagy-lysosome-mediated degradation of ACSL4, and increasing ACSL4 expression could drive ferroptosis [48]